Like I've been saying... they clearly have money lined up b/c they are moving forward with the drug trial approval applications. If the phase 1 tissue studies are positive this will move fast and furious to the upside. Nasdaq reps must have liked what they heard from Dr. Mullen and think the company plan is real.
Just remember 60 Roskamp drs have tested anatabene for 6-7 (allot of testing) years and Dr. M left Roskamp on good terms but Dr.Crawford stayed behind. Connect the dots. Dr.M is either a lunatic or he knows exactly what he is doing. I've heard him speak...he is not anything other than brilliant!
News 
Market Data 
Discover 
